Your browser doesn't support javascript.
loading
The class I HDAC inhibitor Romidepsin targets inflammatory breast cancer tumor emboli and synergizes with paclitaxel to inhibit metastasis.
Robertson, Fredika M; Chu, Khoi; Boley, Kimberly M; Ye, Zaiming; Liu, Hui; Wright, Moishia C; Moraes, Ricardo; Zhang, Xuejun; Green, Tessa L; Barsky, Sanford H; Heise, Carla; Cristofanilli, Massimo.
Afiliação
  • Robertson FM; Department of Experimental Therapeutics, The University of Texas M.D. Anderson Cancer Center, Houston, TX 77030, USA. frobertson@mdanderson.org
  • Chu K; Department of Experimental Therapeutics, The University of Texas M.D. Anderson Cancer Center, Houston, TX 77030, USA.
  • Boley KM; Department of Experimental Therapeutics, The University of Texas M.D. Anderson Cancer Center, Houston, TX 77030, USA.
  • Ye Z; Department of Experimental Therapeutics, The University of Texas M.D. Anderson Cancer Center, Houston, TX 77030, USA.
  • Liu H; Department of Experimental Therapeutics, The University of Texas M.D. Anderson Cancer Center, Houston, TX 77030, USA.
  • Wright MC; Department of Experimental Therapeutics, The University of Texas M.D. Anderson Cancer Center, Houston, TX 77030, USA.
  • Moraes R; Department of Experimental Therapeutics, The University of Texas M.D. Anderson Cancer Center, Houston, TX 77030, USA.
  • Zhang X; Department of Experimental Therapeutics, The University of Texas M.D. Anderson Cancer Center, Houston, TX 77030, USA.
  • Green TL; Department of Experimental Therapeutics, The University of Texas M.D. Anderson Cancer Center, Houston, TX 77030, USA.
  • Barsky SH; The Department of Pathology, The University of Nevada School of Medicine, Reno NV, USA.
  • Heise C; Celgene Corporation, San Francisco, CA, USA.
  • Cristofanilli M; Department of Medical Oncology, Thomas Jefferson University, Philadelphia, PA, USA.
J Exp Ther Oncol ; 10(3): 219-33, 2013.
Article em En | MEDLINE | ID: mdl-24416998
Assuntos
Buscar no Google
Imprimir
XML
PubMed Links

Base de dados: MEDLINE Assunto principal: Paclitaxel / Depsipeptídeos / Inibidores de Histona Desacetilases / Neoplasias Inflamatórias Mamárias / Células Neoplásicas Circulantes Tipo de estudo: Prognostic_studies Limite: Animals / Female / Humans Idioma: En Ano de publicação: 2013 Tipo de documento: Article
Buscar no Google
Imprimir
XML
PubMed Links

Base de dados: MEDLINE Assunto principal: Paclitaxel / Depsipeptídeos / Inibidores de Histona Desacetilases / Neoplasias Inflamatórias Mamárias / Células Neoplásicas Circulantes Tipo de estudo: Prognostic_studies Limite: Animals / Female / Humans Idioma: En Ano de publicação: 2013 Tipo de documento: Article